Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1

Conditions

Breast Neoplasms 51Fallopian Tube Neoplasms 28Ovarian Neoplasms 23Carcinoma, Non-Small-Cell Lung 22Triple Negative Breast Neoplasms 15Pancreatic Neoplasms 13Breast Neoplasms, Male 11Lung Neoplasms 10Brenner Tumor 10Inflammatory Breast Neoplasms 7Uterine Cervical Neoplasms 5Endometrial Adenocarcinoma 5Adenocarcinoma of Lung 5Urinary Bladder Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Melanoma 4Cholangiocarcinoma 4Carcinoma, Ovarian Epithelial 4Adenocarcinoma, Bronchiolo-Alveolar 4Adenocarcinoma Of Esophagus 4Pleural Effusion, Malignant 3Pancreatic Adenocarcinoma 3Neoplasms 3Thymoma 2Neurotoxicity Syndromes 2Gallbladder Neoplasms 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinosarcoma 2Breast Carcinoma In Situ 2

Interventions

Ifosfamide 10Carboplatin 8Paclitaxel 7Etoposide 7Filgrastim 5Dexamethasone 3Cisplatin 3Thiotepa 2Stem Cell Transplantation 2Peripheral Blood Stem Cell Transplantation 2Oxaliplatin 2Ondansetron 2Mesna 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2Calcium Dobesilate 2Bleomycin 2Aprepitant 2tremelimumab 1thymoglobulin 1sodium thiosulfate 1poly ICLC 1pembrolizumab 1pegfilgrastim 1palifosfamide lysine 1palbociclib 1isophosphamide mustard 1fosaprepitant 1etoposide phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Testicular Neoplasms × Taxes × Clear all
NCT00467051 2018-08-29

Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors

Children's Oncology Group

Phase 2 Completed
20 enrolled 8 charts
GenitourinaryGynecologic

Ovarian Germ Cell Cancer, Testicular Neoplasms, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡